Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin and Delayed Graft Function in Renal Allografts from Extended Criteria Donors
2006-005373-22Phase 4Completed
- Sponsor
- Central Manchester University Hospitals NHS Foundation Trust
- Start
- May 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in delayed graft function (DGF) comparing Erythropoietin arm with Placebo arm (2 arms). Primary endpoints: Biomarker plasma levels at 12 months and Biomarker gene expression at 12 months. Started May 2007; status: completed.
02
Drugs
erythropoietin
03
Conditions
delayed graft function (DGF)
Beyond the preview
Go deeper on 2006-005373-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005373-22.